adc-3680
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT01173770)
Timeline
Indications
Studied for
Mechanism of action
- G protein-coupled receptor 44ANTAGONIST
PTGDR2 antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545343 ↗
Also known as
- adc3680
- adc3680
- adc-3680
- adc-3680b
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01730027 | Phase 2 | Apr 1, 2013 | Pulmagen Therapeutics |
| NCT01448954 | Phase 2 | Sep 1, 2011 | Pulmagen Therapeutics |
| NCT01173770 | Phase 1 | Jul 1, 2010 | Pulmagen Therapeutics, Simbec-Orion |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pulmagen Therapeutics | For profit | 3 | 3 | 2 | 2010 |
| Simbec-Orion | For profit | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1